BioCentury
ARTICLE | Company News

UCB, Lonza Ltd. deal

March 6, 2006 8:00 AM UTC

Contract manufacturer Lonza completed its previously announced acquisition of the bioproducts manufacturing division of UCB for E120 million ($142.4 million) in cash (see BioCentury, Jan. 23). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article